Medical Devices & Equipment Company

FBR Medical Inc.


Funding Goal $3,000,000
Funding Raised So Far $0
Funding Commitments $500,000
Funding Remaining $2,500,000
Funding Type Convertible Stock
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Company Overview

FBR develops life-saving cardiac support devices to help heart disease patients recover in a market worth $12 billion. We intend to lead this heart recovery market.

Heart disease is the leading cause of death. To treat heart disease, each year U.S. physicians perform more than two million cardiovascular procedures. Another 400,000 U.S. patients are so sick they cannot even undergo such a life-saving procedure without substantial cardiac support.

New cardiac support devices have emerged that treat heart disease patients and allow them to recover. Most patients recover within hours, and the device is removed.

Our only meaningful competitor was recently acquired for $17B.

Our data indicate our low-cost devices may be more effective and associated with fewer complications than our competitor's. FBR has been granted 13 patents and 14 additional patents are pending.

FBR’s founder has invested $5 M developing our products.

The previous cardiovascular company our founder started was acquired for $1.1B. In addition, our founder was the first Business Development Manager for Gilead Sciences (NASDAQ: GILD), a pioneering biotechnology company.

Our COO has commercialized more than a dozen medical product platforms. He most recently served as a senior operating officer at Clearpoint Neuro (NASDAQ: CLPT) and Edwards Lifesciences (NASDAQ: EW).

We project that in 2026 we will generate $2.8M of revenue and then grow rapidly. By 2030, we forecast $270M of revenue, $67M of operating income, and $47M of net income.

Investors are being offered shares at a substantial discount. We believe at this price investors' IRR could exceed 50%.

We believe this will be our lowest priced offering. We anticipate at least one subsequent offering at a higher valuation.

lock icon

Invest in Company

Sign up or log in now to unlock profile details and access financials, company documents, and invest in companies.

Business Summary

Company Age
Prior Year Revenue
Current Year Revenue
Next Year Revenue


Medical Devices

FBR Medical's proprietary devices deliver blood out of the weak and damaged heart to the oxygen-starved organs, while unloading the damaged heart and allowing it to rest and recover. Most patients will recover within a few hours, and the physician will remove our device.

Our cardiac support devices provide these key advantages over our only meaningful competitor:
- Ease of use
- More blood flow
- Gentler blood flow (less red blood cell destruction, or hemolysis)
- More heart recovery
- Better patient outcomes
- Lower cost

FBR Medical has been issued 13 patents and 14 patents are pending.


Chief Executive Officer
Robert B......

Our founder and CEO incorporated FBR in 2015 and assigned his ownership of the technology to the Company. Since then, he has personally invested more than $4 million in the Company ($5 million including his investments before incorporation.).

Prior to founding FBR, he founded Kriton Medical - which later became HeartWare. During his time as CEO, the company developed a complex cardiovascaular device that generated all of the company's revenue. In 2016, Medtronic (NASDAQ: MDT) acquired HeartWare for $1.1 billion.

Our founder was the original Business Development Manager for then start-up Gilead Sciences (NASDAQ: GILD). He was also a Nomura Research analyst and a Merrill Lynch investment banker.

Our founder was awarded an M.B......A. degree by Harvard and M.D. and A.B...... degrees by Columbia University. He completed post-doctoral research at U.C.S.F. and a medical/surgical internship at California Pacific.

Chief Operating Officer
Peter P......

Our COO most recently served as a senior operating officer at Clearpoint Neuro (NASDAQ: CLPT) and Edwards Lifesciences (NASDAQ: EW). Mr. Piferi has commercialized more than a dozen unique medical product platforms. He has developed numerous technically challenging implantable and disposable medical devices, including a permanent implantable blood pump and complex cardiovascular catheters. Mr. Piferi has been issued 47 patents. He has an from Rensselaer Polytechnic Institute.

Consulting Physician/Medical Officer
Naresh S......

Dr. Solankhi is the Director of the Catheter Laboratory at Jewish Hospital in Louisville, KY as well as an Assistant Clinical Professor of Medicine at the University of Louisville, KY. He has performed thousands of interventional cardiology procedures and has been the local principal investigator for 35 multi-center clinical trials.

Dr. Solankhi completed a residency in internal medicine at The Cleveland Clinic Foundation and fellowships in cardiovascular medicine at Mt. Sinai School of Medicine and interventional cardiology at St. Paul’s Hospital, University of British Columbia.

Consulting Accounting
Kristin D......

- 30+ years experience advising and auditing start-up and emerging growth companies
- Provided audit and tax services for Price Waterhouse
- M.S., taxation, Golden Gate University; B.S., accounting, California State University, Chico


Funding Goal $3,000,000
Funding Raised So Far $0
Funding Commitments $500,000
Funding Remaining $2,500,000
Funding Type Convertible Stock
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding



FBR Medical Inc.

El Dorado Hills, CA 95762, US

Top 10 Tips for Entrepreneurs Seeking Funding

Users who follow these tips increase their fundraising odds substantially.

  • Complete Your Funding Profile
    • Complete your funding profile with all sections filled, including your products and services, a complete management team with headshots, and slideshow with product images.
  • Complete a Business Plan (Optional)
    • Complete a Business Plan in EquityNet and refine your financial projections using the benchmarking alerts in the Business Plan Analysis report.
  • Upload Important Investment Documents
    • Upload and present any other important investment documents such as pitch decks, financial statements, and offering materials.
  • Use EquityNet Crowdcast
    • Use the EquityNet Crowdcast system to automatically email invitations to your contacts in order to build additional exposure for your company.
  • Construct Concise Introductory Messages
    • Construct and send a concise introductory message to investors, including primary reasons why they should want to invest such as KPIs, expected returns, and forecasted revenue.
  • Be Proactive in Messaging Investors
    • Be proactive in messaging many investors and include a simple way for them to connect with you for a web meeting or call, such as a Calendly link.
  • Use the Activity System
    • Use the Activity system to track interested investors, and send prompt follow-up messages to investors who viewed your profile or showed interest.
  • Prepare for Due Diligence
    • Prepare for due diligence questions by interested investors and use your Business Plan and investment documents to satisfy such requests.
  • Keep Your Funding Profile Updated
    • Keep your funding profile updated with new funding raised/committed and message interested investors with any new milestones achieved.
  • Do Not Respond to Unknown Investors
    • Do not respond to or engage any parties outside of EquityNet that are not listed as approved investors (this may happen due to your public profile and LinkedIn connections).